Class III
Terminated
FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4297-31, UPC 3 0054-4297-31 8.
Why: CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
- Company
- Boehringer Ingelheim Roxane Inc
Columbus, OH, United States - Reported
- Oct 21, 2015
- Recall started
- Sep 25, 2015
- Ended
- Feb 19, 2016
- Where sold
- Nationwide and Puerto Rico
- Amount
- 11,110 bottles
- Full product description
- FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4297-31, UPC 3 0054-4297-31 8.
- Lots / codes affected
- Lot #: 559660P, 559661P, Exp 03/17
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.